Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Child Adolesc Psychopharmacol ; 17(6): 831-42, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18315454

RESUMO

INTRODUCTION: The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder (ADHD)-Child Version (LPS-C) was developed to capture treatment-related improvements in adaptive functioning, including quality of life, social development, and emotion regulation, that may be missed by scales that assess only the 18 ADHD symptoms in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). The 24-item LPS-C is intended to augment traditional ADHD measures. This analysis assessed the scale's psychometric properties. METHODS: The LPS-C was completed by the investigators while questioning the parents of 979 children in three placebo-controlled clinical trials that measured the effects of atomoxetine for treating ADHD. In addition to a factor analysis, assessments of responsiveness; internal consistency; item-to-total correlations; and convergent, divergent, and discriminant validity were completed. RESULTS: The LPS-C showed evidence of internal consistency and convergent, divergent, and discriminant validity. The factor analysis suggested two subscales (labeled the Self-Control and Agreeable subscales). The LPS-C demonstrated responsiveness in two of the three trials. The effect sizes suggest responsiveness between that for psychosocial measures and core symptom measures. CONCLUSIONS: The LPS-C appears to be a valid research and clinical instrument for assessing change in ADHD-related adaptive functioning that may not be captured by traditional measures of core ADHD symptoms.


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Escalas de Graduação Psiquiátrica , Qualidade de Vida , Adolescente , Inibidores da Captação Adrenérgica/uso terapêutico , Cloridrato de Atomoxetina , Estimulantes do Sistema Nervoso Central/uso terapêutico , Criança , Emoções/efeitos dos fármacos , Análise Fatorial , Feminino , Humanos , Masculino , Metilfenidato/uso terapêutico , Estudos Multicêntricos como Assunto , Pais , Propilaminas/uso terapêutico , Psicometria/métodos , Ensaios Clínicos Controlados Aleatórios como Assunto , Reprodutibilidade dos Testes , Comportamento Social
2.
J Atten Disord ; 8(3): 127-35, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16009661

RESUMO

Poor outcomes in ADHD may be related to problematic social functioning and consequences of social rejection. This study examines how ADHD symptom expression affects mood and social rejection. Working from findings in depression that describe maintenance through negative interpersonal interactions, the authors seek to examine this theory's applicability to poor outcomes in ADHD. In a completely randomized design, 130 participants are exposed to one of several videotape segments that include displays of ADHD, depression, and social anxiety. A normal control is also used. All abnormal videotapes are met with greater rejection than the control. Displays of ADHD elicit similar levels of rejection to those elicited by displays of depression. Additionally, ADHD elicits greater levels of hostile mood, whereas depression elicits high levels of depression and fatigue. Implications for an interpersonal theory of vulnerability in ADHD are discussed along with implications for future research, prevention, and intervention.


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade/epidemiologia , Rejeição em Psicologia , Comportamento Social , Adulto , Ansiedade/diagnóstico , Transtorno do Deficit de Atenção com Hiperatividade/diagnóstico , Depressão/diagnóstico , Feminino , Humanos , Relações Interpessoais , Masculino , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...